Mehmet Onur Demirkol
Papers
3
Total Citations
21
H-Index
2
About
Mehmet Onur Demirkol is a leading urologic oncologist whose research focuses on refining risk stratification and surgical decision-making in prostate cancer. His work sits at the intersection of advanced imaging, precision pathology, and robotic surgery. A central theme of his contributions is the integration of PSMA PET/CT with multiparametric MRI to improve the accuracy of preoperative staging. He has critically investigated the ability of PSMA PET/CT to predict both pathological upgrading (from low-risk to higher-grade disease) and downgrading (from high-grade biopsy results to less aggressive pathology after surgery), directly challenging the reliability of standard biopsy alone. His 2023 study on predicting upgrading in ISUP grade group 1 patients (9 citations) and his 2024 work on downgrading in Gleason 4+4 disease (2 citations) provide actionable data for avoiding overtreatment and undertreatment. Additionally, his 2023 paper on intraoperative frozen section analysis (10 citations) explores the utility of the Neurosafe technique during robotic radical prostatectomy, helping to identify the ideal candidate for nerve-sparing surgery in the modern era of mpMRI and PSMA-PET staging. Collectively, Demirkol’s work is shaping a more personalized, image-guided approach to prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3